ArticleScientific reports2025
Adenosine improves postmenopausal obesity by regulating neutrophil extracellular traps.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting lipocalin-2 in atherosclerosis: biological functions, pathogenic mechanisms, and therapeutic potential.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Postmenopause marks a critical physiological transition in women, triggering changes in fat distribution and promoting obesity, which is strongly linked to systemic low-grade chronic inflammation, with neutrophil extracellular traps (NETs) playing a pivotal role in this process. Differentially expressed genes (DEGs) related to obesity were identified from the GEO database (GSE44000), followed by protein-protein interaction (PPI) network construction and functional enrichment analysis. Immune infiltration analysis was performed to assess changes in the adipose tissue microenvironment. In vivo, a bilateral ovariectomized (OVX) mouse model was employed to evaluate the effects of adenosine on obesity. RT-qPCR and Western blot were used to assess gene expression and NETs markers. A total of 510 DEGs were identified, with 469 upregulated genes primarily linked to inflammation and immune infiltration. PPI analysis highlighted key genes involved in NETs formation. Immune infiltration analysis revealed significant immune microenvironment alterations. Adenosine treatment in OVX mice reduced body weight, fat tissue, liver lipid deposition, and NETs markers (ELANE, MPO), downregulating TNF, ITGB2, and ITGAM. Adenosine ameliorates postmenopausal obesity by regulating markers of NETs, underscoring the critical role of inflammation in obesity pathogenesis and offering a potential novel therapeutic approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.